Yousif Capital Management LLC Sells 1,665 Shares of Intuitive Surgical, Inc. $ISRG

Yousif Capital Management LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the third quarter, Holdings Channel.com reports. The institutional investor owned 50,487 shares of the medical equipment provider’s stock after selling 1,665 shares during the period. Yousif Capital Management LLC’s holdings in Intuitive Surgical were worth $22,579,000 as of its most recent filing with the SEC.

A number of other large investors have also recently made changes to their positions in ISRG. Tobam boosted its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 2nd quarter worth $30,000. 1248 Management LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth $30,000. Finally, TD Capital Management LLC grew its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Wells Fargo & Company increased their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Daiwa Capital Markets increased their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Leerink Partners raised their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. BTIG Research upped their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Trading Up 1.3%

Intuitive Surgical stock opened at $579.83 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market capitalization of $207.86 billion, a price-to-earnings ratio of 76.70, a P/E/G ratio of 5.26 and a beta of 1.68. The firm has a 50 day moving average of $544.36 and a 200 day moving average of $505.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.84 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction on Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This represents a 83.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the business’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 114,007 shares of company stock worth $63,533,844 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.